SPRTN and metabolic dysfunction-associated steatotic liver disease: It remains to be seen if aldehyde levels are higher in SPRTN deficient cells or if SPRTN deficiency in conjunction with non-alcoholic fatty liver disease cause increased DPC formation and hepatocellular carcinoma development.